D. M. . Jiang, R. J. . Hamilton, and A. R. . Hansen, “Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time ”, CUAJ, vol. 14, no. 2, pp. 48–9, Jan. 2020.